Valsartan Tablets
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency (DLA) Troop Support plans to issue a solicitation for a national requirements contract to supply Valsartan Tablets in various dosages and packaging configurations, including 40 mg tablets available in 30 and 90 count bottles, as well as 80 mg, 160 mg, and 320 mg tablets in 90 count bottles. This procurement will be an unrestricted, fully competitive acquisition under a firm-fixed price, requirements-type contract structure, featuring a one-year base period with four additional one-year option periods. The contract aims to establish a national supply source for multiple federal agencies, including the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons, facilitating purchases primarily through DLA and VA prime vendor programs. Annual usage estimates will be disclosed in the solicitation schedule, and proposals will be considered from all interested sources under FAR Part 12 as this is a commercial item acquisition. The solicitation, identified as SPE2D2-26-R-0011, is projected to be posted in June 2026 on the DLA Bid Board System (DIBBS) and sam.gov websites. Potential bidders are encouraged to set up automated notifications for updates or changes to the solicitation. For additional information or inquiries, contacts are provided, with Ryan Guarnere serving as the primary point of contact. The performance and delivery locations are not specifically defined, and the contract will be conducted under NAICS code 325412, pertaining to pharmaceutical preparation manufacturing. DLA maintains the flexibility to release the solicitation earlier or later than the planned date.
General Info
Agency
NAICS
Place of Performance
PASet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Valsartan Tablets. Procurement details follow.
Valsartan 40 MG tablets in 30 and 90 count bottles and 80 MG, 160 MG, and 320 MG in 90 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Sam.gov at https://sam.gov/. Interested parties should contact Ryan Guarnere (445-737-1729) (Ryan.Guarnere@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is June 2026. DLA reserves the right to issue the solicitation before or after the projected solicitation date.